Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The VETERANS AFFAIRS, DEPARTMENT OF has issued a Tender notice for the procurement of a Liposome Preparation for Experimental Rheumatoid Arthritis Treatment in the USA. This Tender notice was published on 17 Jul 2026 and is scheduled to close on 31 Jul 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145331656, while the tender notice number is 36C24526Q0665 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Liposome Preparation for Experimental Rheumatoid Arthritis Treatment
Deadline: 31 Jul 2026
Posting Date: 17 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145331656
Document Ref. No.: 36C24526Q0665
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
SOURCES SOUGHT NOTICE
Joint Targeted Drug Delivery Approach for Arthritis Therapy Liposome Preparation
Department of Veterans Affairs Network Contracting Office 05 (NCO 05)
1. Purpose
The Department of Veterans Affairs (VA) is conducting market research to identify qualified and experienced sources capable of producing specialized liposomal formulations incorporating patented joint targeting technologies. This notice is issued solely for information and planning purposes and does not constitute a solicitation.
The VA seeks vendors capable of custom nanoparticle/liposome formulation, peptide functionalized delivery systems, drug encapsulation, and nanoparticle characterization.
2. Description of Requirement (High Level)
The anticipated requirement includes preparation of liposomes using a patented lipid composition and a patented targeting peptide (ART 2), loading an anti arthritis drug, and performing standard physicochemical characterization.
To protect VA owned intellectual property:
Only limited non proprietary details are being released at this stage.
Full technical specifications including the proprietary lipid composition, ratios, and ART 2 functionalization method will only be released after execution of a Confidential Disclosure Agreement (CDA) with the VA Technology Transfer Program.
3. Key Capability Areas of Interest
Vendors should demonstrate capability and experience in the following areas:
Custom liposome or nanoparticle formulation using sponsor specified lipid systems.
Experience incorporating targeting peptides or ligands onto nanoparticle surfaces.
Ability to encapsulate therapeutic compounds (e.g., dexamethasone) with documented encapsulation efficiency.
Analytical capability for nanoparticle characterization, including:
Particle size (nm)
Zeta potential/surface charge
Polydispersity Index (PDI)
Drug loading quantification via LC MS/MS or HPLC
Ability to deliver research grade formul...
Notice ID: 36c24526q0665
Department/Ind. Agency: veterans affairs, department of
Sub-tier: veterans affairs, department of
Office: 245-network contract office 5 (36c245)
Product Service Code: aj13 - general science & technology r&d svcs; general science & technology; experimental development
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Inactive Dates: sep 29, 2026
Inactive Policy: manual
Documents
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google